Literature DB >> 19735389

Breast intracystic papillary carcinoma: an update.

Julien Calderaro1, Marc Espie, Juliette Duclos, Sylvie Giachetti, Delphine Wehrer, Wissam Sandid, Laurence Cahen-Doidy, Marcella Albiter, Anne Janin, Anne de Roquancourt.   

Abstract

Intracystic papillary carcinoma (IPC), a breast tumor mainly occuring in the elderly, has long been considered as a variant of ductal carcinoma in situ (DCIS). This is now debated since metastatic cases have been reported. In this study, surgical pieces of 20 IPCs were reassessed, and markers of myopepithelial layer (p63, CD10 and Smooth Muscle Actin) as well as estrogen receptors (ER) and progesterone receptors (PgR) and C-erb-B2 oncoprotein expression were systematically performed and quantified. In 10 cases, an associated unequivocal invasive component was found. In all 20 cases, no myoepithelial layer was found. Eighteen tumors were ER positive, 14 were PgR positive. Moreover, none of the tumors over-expressed C-erb-B2 oncoprotein. Therefore this study showed that in all cases of IPC there were microscopic features of invasive carcinoma despite good clinical prognostic indicators, and that precise characterization of tumors requires extensive paraffin embedding of surgical pieces.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19735389     DOI: 10.1111/j.1524-4741.2009.00823.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  13 in total

1.  Intracystic papillary carcinoma of the breast: A SEER database analysis of implications for therapy.

Authors:  Harveshp Mogal; Doris R Brown; Scott Isom; Kayla Griffith; Marissa Howard-McNatt
Journal:  Breast       Date:  2016-04-04       Impact factor: 4.380

2.  An intracystic papillary carcinoma of the breast.

Authors:  Donya Farrokh; Mahboobeh Abedi; Yalda Fallah Rastegar
Journal:  Iran J Cancer Prev       Date:  2013

3.  Intracystic Papillary Carcinoma in Male Breast with High Nuclear Grade: A Case Report.

Authors:  Abdulaziz Ajlan M Al Salloom
Journal:  J Clin Diagn Res       Date:  2015-08-01

4.  Intracystic Carcinoma of the Breast: Report of Two Cases.

Authors:  Enver İlhan; Orhan Üreyen; Abdullah Şenlikci; Ayşe Yağcı; Eyüp Yeldan; Tarık Salman; Mehmet Tahsin Tekeli
Journal:  J Breast Health       Date:  2015-01-01

5.  Intracystic papillary carcinoma of breast: interrelationship with in situ and invasive carcinoma and a proposal of pathogenesis: array comparative genomic hybridization study of 14 cases.

Authors:  Thaer Khoury; Qiang Hu; Song Liu; Jianmin Wang
Journal:  Mod Pathol       Date:  2013-08-02       Impact factor: 7.842

6.  8p deletion is strongly linked to poor prognosis in breast cancer.

Authors:  P Lebok; A Mittenzwei; M Kluth; C Özden; B Taskin; K Hussein; K Möller; A Hartmann; A Lebeau; I Witzel; S Mahner; L Wölber; F Jänicke; S Geist; P Paluchowski; C Wilke; U Heilenkötter; R Simon; G Sauter; L Terracciano; R Krech; A von der Assen; V Müller; E Burandt
Journal:  Cancer Biol Ther       Date:  2015-05-11       Impact factor: 4.742

7.  The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis.

Authors:  Gulisa Turashvili; Edi Brogi; Monica Morrow; Clifford Hudis; Maura Dickler; Larry Norton; Hannah Y Wen
Journal:  Breast Cancer Res Treat       Date:  2017-06-03       Impact factor: 4.872

Review 8.  Papillary carcinoma of breast: Minireview.

Authors:  Sachin B Ingle; Hemant G Murdeshwar; Saleha Siddiqui
Journal:  World J Clin Cases       Date:  2016-01-16       Impact factor: 1.337

9.  Diagnosis, treatment, and outcomes of encapsulated papillary carcinoma: a single institution experience.

Authors:  Laura Steponavičienė; Daiva Gudavičienė; Rūta Briedienė; Donatas Petroška; Aušra Garnelytė
Journal:  Acta Med Litu       Date:  2018

10.  "Intracystic papillary breast cancer: a clinical update".

Authors:  Sara Al Reefy; Rashid Kameshki; Dhabya Al Sada; Abdullah Al Elewah; Arwa Al Awadhi; Kamil Al Awadhi
Journal:  Ecancermedicalscience       Date:  2013-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.